©2025 Bryn Mawr Communications, LLC.
All Rights Reserved

Terms and Conditions • Privacy Policy

Meeting Coverage:

American Academy of Ophthalmology

AAO: 2023

Diversity in Ocular Oncology

Basil K. Williams Jr, MD

Show Description +

Basil K. Williams Jr, MD, discusses the health disparities in the care of patients with retinal blastoma, choroidal melanoma, lymphoma, and ocular surface squamous neoplasia.

Posted: 11/20/2023

Keywords:

retina-meeting-recap

•

retinal blastoma

•

Choroidal melanoma

•

lymphoma

•

ocular surface squamous neoplasia

•

Diversity

•

Retina Subspecialty Day

Up Next

The Latest in Retina Surgical Instrumentation
The Latest in Retina Surgical Instrumentation

David R. Chow, MD

Update on Glaucoma Lasers
Update on Glaucoma Lasers

Aaki Shukla, MD, and Mary Qiu, MD

Impact of 6-Week Treatment With Lotilaner Ophthalmic Solution, 0.25% on Eyes With Severe Demodex Blepharitis
Impact of 6-Week Treatment With Lotilaner Ophthalmic Solution, 0.25% on Eyes With Severe Demodex Blepharitis

Mitchell Shultz, MD

Walking Over a Flat Earth: A Jump Toward Diversity, Equity, and Inclusion (DEI)
Walking Over a Flat Earth: A Jump Toward Diversity, Equity, and Inclusion (DEI)

Basil Williams, MD

Rethinking Refractive Surgery: What’s New In 2023?
Rethinking Refractive Surgery: What’s New In 2023?

George O. Waring IV, MD, FACS

Intracameral Low Molecular Weight Heparin for DMEK: A Pilot Safety Study
Intracameral Low Molecular Weight Heparin for DMEK: A Pilot Safety Study

Rahul Tonk, MD, MBA

Combination Therapy in the Treatment of Dry Eye vs. Traditional Cyclosporine
Combination Therapy in the Treatment of Dry Eye vs. Traditional Cyclosporine

John A. Hovanesian, MD

Wet AMD Gene Therapy at 3 Years: Ixo-vec
Wet AMD Gene Therapy at 3 Years: Ixo-vec

Carl D. Regillo, MD, FACS

Pegcetacoplan Extension Study Update
Pegcetacoplan Extension Study Update

Jeffrey S. Heier, MD

Two Years of Treatment with Avacincaptad Pegol
Two Years of Treatment with Avacincaptad Pegol

Arshad M. Khanani, MD, MA

Efficacy of Faricimab with PEDs Revealed
Efficacy of Faricimab with PEDs Revealed

Jennifer I. Lim, MD

Genetics: Now or Later
Genetics: Now or Later

Inas Aboobakar, MD

New Glaucoma Devices in the Pipeline
New Glaucoma Devices in the Pipeline

Matt Schlenker, MD

Virtual Visual Fields: Are They Ready for Prime Time?
Virtual Visual Fields: Are They Ready for Prime Time?

Steven R. Sarkisian Jr, MD

Cutting-Edge Translational Research From the Next Generation
Cutting-Edge Translational Research From the Next Generation

Jodhbir Singh Mehta, MD, PhD

Visual Outcomes With a Small-Aperture IOL in Post-Radial Keratotomy Patients
Visual Outcomes With a Small-Aperture IOL in Post-Radial Keratotomy Patients

Sudhinder Koushik, MD

Drug-Eluting IOLs
Drug-Eluting IOLs

Kenneth Mandell, MD, PhD

Pearls for Subretinal Gene Therapy
Pearls for Subretinal Gene Therapy

Christina Y. Weng, MD, MBA

A CRISPR Gene Editing Update
A CRISPR Gene Editing Update

Glenn Yiu, MD, PhD

A New Approach to Combatting Blindness in RP
A New Approach to Combatting Blindness in RP

Russell N. Van Gelder, MD, PhD

Tackling TRDs with Limited Membranectomy
Tackling TRDs with Limited Membranectomy

John W. Kitchens, MD

Working Toward Diversity in Retina Clinical Trials
Working Toward Diversity in Retina Clinical Trials

Adrienne W. Scott, MD

link-arrow   Back to All Videos

Diversity in Ocular Oncology

Basil K. Williams Jr, MD

Basil K. Williams Jr, MD, discusses the health disparities in the care of patients with retinal blastoma, choroidal melanoma, lymphoma, and ocular surface squamous neoplasia.

Posted: 11/20/2023

Keywords:

retina-meeting-recap

•

retinal blastoma

•

Choroidal melanoma

•

lymphoma

•

ocular surface squamous neoplasia

•

Diversity

•

Retina Subspecialty Day

Please log in to leave a comment.

More From AAO: 2023 Coverage

Pearls for Subretinal Gene Therapy
Pearls for Subretinal Gene Therapy

Christina Y. Weng, MD, MBA

A CRISPR Gene Editing Update
A CRISPR Gene Editing Update

Glenn Yiu, MD, PhD

A New Approach to Combatting Blindness in RP
A New Approach to Combatting Blindness in RP

Russell N. Van Gelder, MD, PhD

Tackling TRDs with Limited Membranectomy
Tackling TRDs with Limited Membranectomy

John W. Kitchens, MD

Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of AAO: 2023.

close-x